Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Nature Neuroscience
|
October 11, 2001
GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons
F Yang, L Feng, F Zheng, et al.
Analytical Biochemistry
|
May 1, 1996
Identification of zinc finger mRNAs using domain-specific differential display
S W Johnson, N A Lissy, P D Miller, et al.
Cancer Research
|
March 15, 1997
The chemopreventive agent oltipraz stimulates repair of damaged DNA
P J O'Dwyer, S W Johnson, C Khater, et al.
Cancer Research
|
October 1, 1995
Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines
K S Yao, A K Godwin, S W Johnson, et al.
Archives of Toxicology
|
January 1, 1997
DNA binding activity of the mammalian translation elongation complex: recognition of chromium- and transplatin-damaged DNA
J F Wang, B N Engelsberg, S W Johnson, et al.
Cancer Research
|
November 15, 1994
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells
S W Johnson, P A Swiggard, L M Handel, et al.
Molecular Pharmacology
|
April 30, 1999
Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers
B J Maurer, M A Ihnat, C Morgan, et al.
Biochemical Pharmacology
|
February 11, 1994
Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
S W Johnson, R P Perez, A K Godwin, et al.
British Journal of Cancer
|
September 14, 2006
Gene expression profiling of human ovarian tumours
S Biade, M Marinucci, J Schick, et al.
British Journal of Cancer
|
February 24, 2005
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
D Roberts, J Schick, S Conway, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Nature Neuroscience
|
October 11, 2001
GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons
F Yang, L Feng, F Zheng, et al.
Analytical Biochemistry
|
May 1, 1996
Identification of zinc finger mRNAs using domain-specific differential display
S W Johnson, N A Lissy, P D Miller, et al.
Cancer Research
|
March 15, 1997
The chemopreventive agent oltipraz stimulates repair of damaged DNA
P J O'Dwyer, S W Johnson, C Khater, et al.
Cancer Research
|
October 1, 1995
Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines
K S Yao, A K Godwin, S W Johnson, et al.
Archives of Toxicology
|
January 1, 1997
DNA binding activity of the mammalian translation elongation complex: recognition of chromium- and transplatin-damaged DNA
J F Wang, B N Engelsberg, S W Johnson, et al.
Cancer Research
|
November 15, 1994
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells
S W Johnson, P A Swiggard, L M Handel, et al.
Molecular Pharmacology
|
April 30, 1999
Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers
B J Maurer, M A Ihnat, C Morgan, et al.
Biochemical Pharmacology
|
February 11, 1994
Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
S W Johnson, R P Perez, A K Godwin, et al.
British Journal of Cancer
|
September 14, 2006
Gene expression profiling of human ovarian tumours
S Biade, M Marinucci, J Schick, et al.
British Journal of Cancer
|
February 24, 2005
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
D Roberts, J Schick, S Conway, et al.
Page
of 12